Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Artivion Inc 1655 Roberts Boulevard NW Kennesaw GA 30144 USA

www.artivion.com Employees: 1,600 P: 770-419-3355

Sector:

Medical

Description:

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia.

Key Statistics

Overview:

Market Capitalization, $K 2,099,186
Enterprise Value, $K 2,360,076
Shares Outstanding, K 47,375
Float, K 43,775
% Float 92.40%
Short Interest, K 1,418
Short Float 2.99%
Days to Cover 3.90
Short Volume Ratio 0.36
% of Insider Shareholders 7.60%
% of Institutional Shareholders 86.37%

Financials:

Annual Sales, $ 388,540 K
Annual Net Income, $ -13,360 K
Last Quarter Sales, $ 113,390 K
Last Quarter Net Income, $ 6,500 K
EBIT, $ 25,730 K
EBITDA, $ 49,940 K

Growth:

1-Year Return 42.69%
3-Year Return 254.48%
5-Year Return 85.17%
5-Year Revenue Growth 40.66%
5-Year Earnings Growth -19.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.16 on 11/06/25
Next Earnings Date 02/23/26
Earnings Per Share ttm 0.46
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year 33.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.030 on 12/09/15
Dividend Payout Ratio 0.00%
Most Recent Split 3-2 on 12/28/00

AORT Ratios

Ratio
Price/Earnings ttm 94.59
Price/Earnings forward 65.92
Price/Earnings to Growth N/A
Return-on-Equity % 5.98%
Return-on-Assets % 2.61%
Profit Margin % -3.44%
Debt/Equity 0.49
Price/Sales 4.63
Price/Cash Flow 52.15
Price/Book 4.68
Book Value/Share 9.30
Interest Coverage -0.78
60-Month Beta 1.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar